Rebecca Cook

Array ( [id] => 1440431 [patent_doc_number] => 06495592 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Tracheal smooth muscle relaxants' [patent_app_type] => B1 [patent_app_number] => 09/609310 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24749 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495592.pdf [firstpage_image] =>[orig_patent_app_number] => 09609310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024967 [patent_doc_number] => 06884818 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Pharmaceutical compositions containing 8-chloro-3 (β-diethylaminoethyl)-4-methyl-7-ethoxycarbonylmethoxy coumarin base and the salts thereof with cholesterol-lowering activity' [patent_app_type] => utility [patent_app_number] => 10/009689 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1832 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884818.pdf [firstpage_image] =>[orig_patent_app_number] => 10009689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312140 [patent_doc_number] => 06613802 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia' [patent_app_type] => B1 [patent_app_number] => 09/585907 [patent_app_country] => US [patent_app_date] => 2000-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 21702 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613802.pdf [firstpage_image] =>[orig_patent_app_number] => 09585907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369982 [patent_doc_number] => 06566404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Treatment of drug-induced sleepiness' [patent_app_type] => B2 [patent_app_number] => 09/554682 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2187 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566404.pdf [firstpage_image] =>[orig_patent_app_number] => 09554682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009450 [patent_doc_number] => 06900212 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts' [patent_app_type] => utility [patent_app_number] => 09/979922 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9690 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900212.pdf [firstpage_image] =>[orig_patent_app_number] => 09979922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686864 [patent_doc_number] => 07078395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-18 [patent_title] => 'Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling' [patent_app_type] => utility [patent_app_number] => 09/561453 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17906 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078395.pdf [firstpage_image] =>[orig_patent_app_number] => 09561453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462964 [patent_doc_number] => 06350782 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Use of basic amino acids derivatives for lowering ceramide levels' [patent_app_type] => B1 [patent_app_number] => 09/558860 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1825 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350782.pdf [firstpage_image] =>[orig_patent_app_number] => 09558860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7620017 [patent_doc_number] => 06943166 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-13 [patent_title] => 'Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction' [patent_app_type] => utility [patent_app_number] => 10/031556 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7232 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943166.pdf [firstpage_image] =>[orig_patent_app_number] => 10031556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889134 [patent_doc_number] => 20020013303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Use of aldosterone antagonists to inhibit myocardial fibrosis' [patent_app_type] => new [patent_app_number] => 09/556352 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6581 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013303.pdf [firstpage_image] =>[orig_patent_app_number] => 09556352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758259 [patent_doc_number] => 07015251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Combinations of ceramide and chemotherapeutic agents for inducing tumor cell death' [patent_app_type] => utility [patent_app_number] => 09/958453 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 47 [patent_no_of_words] => 19083 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015251.pdf [firstpage_image] =>[orig_patent_app_number] => 09958453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383375 [patent_doc_number] => 06294565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Methods of combatting infectious diseases using dicationic bis-benzimidazoles' [patent_app_type] => 1 [patent_app_number] => 9/544643 [patent_app_country] => US [patent_app_date] => 2000-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7307 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294565.pdf [firstpage_image] =>[orig_patent_app_number] => 544643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494488 [patent_doc_number] => 06342482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Formulations for controlling human lice' [patent_app_type] => B1 [patent_app_number] => 09/543441 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9147 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342482.pdf [firstpage_image] =>[orig_patent_app_number] => 09543441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404460 [patent_doc_number] => 06534511 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Bicyclic heterocyclic compounds for the treatment of impotence' [patent_app_type] => B1 [patent_app_number] => 09/542489 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3683 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534511.pdf [firstpage_image] =>[orig_patent_app_number] => 09542489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373229 [patent_doc_number] => 06562794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Cosmetic and dermatological formulations comprising flavonoids' [patent_app_type] => B1 [patent_app_number] => 09/540007 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8599 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562794.pdf [firstpage_image] =>[orig_patent_app_number] => 09540007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543335 [patent_doc_number] => 06372798 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Treatment of hyperactivity disorders' [patent_app_type] => B1 [patent_app_number] => 09/528046 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2485 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372798.pdf [firstpage_image] =>[orig_patent_app_number] => 09528046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736100 [patent_doc_number] => 20030013735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Weight loss after pregnancy' [patent_app_type] => new [patent_app_number] => 09/528801 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2285 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013735.pdf [firstpage_image] =>[orig_patent_app_number] => 09528801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495747 [patent_doc_number] => 06403650 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Treatment of pulmonary hypertension' [patent_app_type] => B1 [patent_app_number] => 09/527815 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2367 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403650.pdf [firstpage_image] =>[orig_patent_app_number] => 09527815 [rel_patent_id] =>[rel_patent_doc_number] =>)